- Entasobulin (Catalog No# : 186293, Cas# : 501921-61-5) Entasobulin is a β-tubulin polymerization inhibitor with potential anticancer activity.
- Epothilone D (Catalog No# : 186292, Cas# : 189453-10-9) Epothilone D is a natural polyketide compound isolated from the myxobacterium Sorangium cellulosum.
- EZM2302 (Catalog No# : 186272, Cas# : 1628830-21-6) EZM2302 is a potent, selective, and orally available arginine methyltransferase CARM1 inhibitor.
- Exatecan mesylate (Catalog No# : 186271, Cas# : 169869-90-3) Exatecan, also known as DX 8951, is semisynthetic, water-soluble camptothecin derivative with antineoplastic activity.
- Efinaconazole (Catalog No# : 186213, Cas# : 164650-44-6) Efinaconazole is a triazole antifungal. It is approved for use in Canada and the USA as a 10% topical solution for the treatment of onychomycosis.
- Erteberel (Catalog No# : 186157, Cas# : 533884-09-2) Erteberel, also known as LY500307, is a selective estrogen receptor beta (ERβ) agonist that was developed for the treatment of benign prostatic hyperplasia.
- Edonerpic maleate (Catalog No# : 18671, Cas# : 519187-97-4) Edonerpic, also known as T-817, is a neuroprotectant.
- Evobrutinib (Catalog No# : 18543, Cas# : 1415823-73-2) Evobrutinib, also known as M-2951 and MSC-2364447C, is a highly selective inhibitor of the Bruton’s tyrosine kinase (BTK).
- Endoxifen E-isomer HCl (Catalog No# : 184124, Cas# : 1197194-61-8) Endoxifen E-isomer is a tamoxifen metabolite and potent Selective Estrogen Response Modifier (SERM).
- Ensartinib (Catalog No# : 184321, Cas# : 1370651-20-9) Ensartinib, also known as X-396, is an orally available small molecule inhibitor of the receptor tyrosine kinase anaplastic lymphoma kinase (ALK) with potential antineoplastic ac
- eCF506 (Catalog No# : 18382, Cas# : 1914078-41-3) eCF506 targets a molecule called Src tyrosine kinase that is required for breast cancer cells to grow and spread. eCF506 may be highly effective at blocking growth of breast canc
- Etifoxine HCl (Catalog No# : 1712142, Cas# : 56776-32-0) Etifoxine, also known as HOE 36801 and etafenoxine, is an anxiolytic and anticonvulsant drug developed by Hoechst in the 1960s.
- Esaxerenone (Catalog No# : 1710121, Cas# : 1632006-28-0) Esaxerenone (INN) (developmental code names CS-3150, XL-550) is a nonsteroidal antimineralocorticoid which was discovered by Exelixis and is now under development by Daiichi Sank
- EBE-A22 (Catalog No# : 179831, Cas# : 229476-53-3) EBE-A22 is a derivative of PD 153035. EBE-A22, has no effect on EGF-R TK but maintains a high cytotoxic profile. EBE-A22 binds to DNA and behave as typical intercalating agents.
- EPZ015666 (Catalog No# : 011309, Cas# : 1616391-65-1) EPZ015666 is a potent, selective and orally bioavailable PRMT5 inhibitor with Ki of 5 nM, >20,000-fold selectivity over other PMTs.
- EED226 (Catalog No# : 178311, Cas# : 2083627-02-3) EED226 is a potent, selective, and orally bioavailable EED inhibitor. induces robust and sustained tumor regression in EZH2MUT preclinical DLBCL model.
- Erdafitinib(JNJ-42756493) (Catalog No# : 651701, Cas# : 1346242-81-6) Erdafitinib(JNJ-42756493) is a potent and selective panfibroblast growth factor receptor (FGFR 1, 2, 3 and 4)oral inhibitor.
- Ethyl 2-cyclohexyl-2-oxoacetate (Catalog No# : 178157, Cas# : 13275-31-5) Ethyl 2-cyclohexyl-2-oxoacetate
- E7449 (Catalog No# : 178903, Cas# : 1140964-99-3) E7449 is an orally available small molecule inhibitor of the nuclear enzymes poly (ADP-ribose) polymerase (PARP) 1 and 2, with potential antineoplastic activity.
- Elenbecestat(E2609) (Catalog No# : 2017878, Cas# : 1388149-30-1) Elenbecestat,also known as E2609 is a BACE1 inhibitor.
- Etoposide Phosphate (Catalog No# : 20178213, Cas# : 117091-64-2) Etoposide phosphate is a phosphate salt of a semisynthetic derivative of podophyllotoxin.
- Elamipretide (Catalog No# : 20178210, Cas# : 736992-21-5) Elamipretide, also known as MTP-131 or D-Arg-Dmt-Lys-Phe-NH2,is a cardiolipin peroxidase inhibitor and mitochondria-targeted peptide.
- erythro-N-Boc-L-3,5-difluorophenylalanine epoxide (Catalog No# : 20177314, Cas# : 388071-27-0) ERYTHRO-N-BOC-L-3,5-DIFLUOROPHENYLALANINE EPOXIDE
- Etrasimod (Catalog No# : 17031018, Cas# : 1206123-37-6) Etrasimod, also known as APD334, is a potent, centrally available, functional antagonists of the S1P1 receptor for use as next generation therapeutics for treating multiple scler
- eFT-508 (Catalog No# : 17031010, Cas# : 1849590-01-7) eFT-508 (eFT508) is a potent and selective MNK1/2 inhibitor, potentially resulting in decreased tumor cell proliferation and tumor growth.
- Epetraborole hydrochloride (Catalog No# : 17022806, Cas# : 1234563-16-6) Epetraborole hydrochloride is a novel leucyl-tRNA synthetase (LeuRS) inhibitor.
- Eliglustat (Catalog No# : 17022718, Cas# : 491833-29-5) Eliglustat, also known as Genz-112638, is is a potent and selective glucosylceramide synthase inhibitor. Eliglustat was approved for Gaucher's disease. Commonly used as the tartr
- EX-527 S-enantiomer (Catalog No# : 17011802, Cas# : 848193-68-0) EX-527 S-enantiomer is a potent and selective SIRT1 inhibitor with IC50 of 123 nM; no inhibition on SIRT3 . EX-527 S-enantiomer is the S-enantiomer of EX-527, EX-527 racemic has
- EX-527 R-enantiomer (Catalog No# : 17011801, Cas# : 848193-69-1) EX-527 R-enantiomer is a negative control of the active form EX-527 S-enantiomer(Speculated for reference); IC50 > 100 uM, e1/e2 can be found in the reference paper. EX-527 S-
- 4E1RCat (Catalog No# : 17011301, Cas# : 328998-25-0) 4E1RCat is an inhibitor of the eIF4F translation initiation complex that blocks eIF4E:eIF4G and eIF4E:4E-BP1 interactions.
Products Catalog
- Bioactive Small Molecules
-
- --- Cancer
- --- Infection
- --- Inflammation/Immunology
- --- Endocrinology /Metabolic
- --- Neurological Disease
- --- Stem Cells
- --- Other inhibitors
- Building blocks
-
- --- phenyl compounds
- --- Heterocyclic Compounds
- --- Boronic Acids
- --- Nitriles
- --- Other Building blocks